EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options

Michela Palleschi, Alessandro Viansone, Filippo Merloni, Caterina Gianni, Alberto Farolfi, Giulia Miserocchi, Marita Mariotti, Giandomenico Di Menna, Olga Serra, Chiara Casadei, Simone Sabbioni, Andrea Carlini und 7 weitere

Cancer Treatment Reviews · 2026-11 · 150 · 103218

DOI: 10.1016/j.ctrv.2026.103218 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von Michela Palleschi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Government Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleProtein Kinase Inhibitors

Stichwörter der Autor:innen

Brain metastasesHER2- targeted therapyHER2-positive metastatic breast cancerantibody-drug conjugatesbiomarkersmaintenance therapyprecision oncologytrastuzumab deruxtecantreatment resistancetreatment sequencing

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: michela.palleschi@irst.emr.it.
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: alessandro.viansone@gustaveroussy.fr.
  • Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: filippo.merloni@irst.emr.it.
  • Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: caterina.gianni@irst.emr.it.
  • Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: alberto.farolfi@irst.emr.it.
  • Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: giulia.miserocchi@irst.emr.it.

Förderung

  • Italian Government Ministry of Health

Zitieren

APA

Palleschi, M., Viansone, A., Merloni, F., Gianni, C., Farolfi, A., Miserocchi, G., Mariotti, M., Di Menna, G., Serra, O., Casadei, C., Sabbioni, S., Carlini, A., Montanari, D., Sirico, M., Mannozzi, F., Tegas, M., Cecconetto, L., Sarti, S., & Musolino, A. (2026). Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options. Cancer Treatment Reviews, 150, 103218. https://doi.org/10.1016/j.ctrv.2026.103218

Vancouver

Palleschi M, Viansone A, Merloni F, Gianni C, Farolfi A, Miserocchi G, et al. Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options. Cancer Treatment Reviews. 2026;150:103218. doi:10.1016/j.ctrv.2026.103218

BibTeX
@article{Palleschi2026,
  author = {Palleschi, Michela and Viansone, Alessandro and Merloni, Filippo and Gianni, Caterina and Farolfi, Alberto and Miserocchi, Giulia and Mariotti, Marita and Di Menna, Giandomenico and Serra, Olga and Casadei, Chiara and Sabbioni, Simone and Carlini, Andrea and Montanari, Daniela and Sirico, Marianna and Mannozzi, Francesca and Tegas, Martina and Cecconetto, Lorenzo and Sarti, Samanta and Musolino, Antonino},
  title = {Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {150},
  pages = {103218},
  doi = {10.1016/j.ctrv.2026.103218}
}
Kostenlos starten →